Robert Abernathy's Trading History
| AVNTAvient | Oct 02, 2026 | Director | Uninformative Buy | ― | $1.84M | |
| HAEHaemonetics | Jul 28, 2026 | Director | Uninformative Buy | ― | $3.29M | |
| AVNSAvanos Medical | May 03, 2017 | ― | Uninformative Sell | 725.46K | $2.00M | |
| KMBKimberly Clark | Apr 30, 2014 | EVP | Uninformative Sell | 2.11M | $8.60M | |
| RSHCQRS Legacy Corporation | Aug 06, 2013 | ― | Informative Buy | 254.06K | $7.60K |
You May Also Like
Robert Abernathy insider profile FAQ
What is the percentage of profitable transactions made by Robert Abernathy?
The percentage of profitable transactions made by Robert Abernathy is 33%.
What is the average return per transaction made by Robert Abernathy?
The average return per transaction made by Robert Abernathy is -3.70%.
What stocks does Robert Abernathy hold?
Robert Abernathy holds: AVNT, HAE, AVNS, KMB, RSHCQ stocks.
What was Robert Abernathy's most profitable transaction?
Robert Abernathy’s most profitable transaction was an Informative Buy of AVNS stock on September 8, 2015. The return on the trade was 16.50%.
What is Robert Abernathy's role in Avient?
Robert Abernathy's role in Avient is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.